The drug repositioning Market is gaining importance as pharmaceutical companies increasingly explore new therapeutic applications for existing medicines. Also known as drug repurposing, this approach can help researchers identify alternative uses for established drugs rather than developing entirely new compounds from the beginning.

According to a recent report by Wise Guys Report, the global Drug Repositioning Market was valued at USD 13.5 billion in 2024 and is projected to reach USD 25 billion by 2035, expanding at a CAGR of 5.8% during the forecast period.

Key Market Drivers

One of the major advantages of drug repositioning is its potential to reduce development time and research costs. Existing medicines may already have safety, pharmacokinetic, and manufacturing information available, allowing researchers to focus on evaluating new therapeutic applications.

Artificial intelligence, machine learning, bioinformatics, and advanced data analytics are also transforming the repositioning process. These technologies can help researchers examine large datasets and identify relationships between existing drugs, biological targets, and diseases. Oncology, neurology, cardiology, infectious diseases, and metabolic disorders are among the important application areas identified for the market.

Future Outlook

The Drug Repositioning Market is expected to benefit from pharmaceutical R&D investment, increasing demand for cost-efficient therapies, and advances in computational drug discovery. Partnerships between pharmaceutical companies, biotechnology firms, research institutions, and contract research organizations may further accelerate innovation.

As healthcare systems seek faster and more economical approaches to therapeutic development, drug repositioning is likely to remain an important strategy within pharmaceutical research.

Frequently Asked Questions

1. What is drug repositioning?
Drug repositioning involves identifying new medical uses for existing or previously developed drugs.

2. Why is drug repositioning important?
It can potentially reduce development time, research costs, and some risks associated with developing completely new medicines.

3. Which technologies support the market?
Artificial intelligence, machine learning, bioinformatics, and data analytics are increasingly supporting drug repositioning research.

4. Which therapeutic areas use drug repositioning?
Oncology, neurology, cardiology, infectious diseases, and metabolic disorders are important application areas.